Vertex Pharmaceuticals Incorporated Stock Buenos Aires S.E.
Stocks
VRTX
AR0468655268
Pharmaceuticals
|
End-of-day quote
Buenos Aires S.E.
2026-10-21
|
5-day change | 1st Jan Change | ||
| 8,470.00 ARS | +1.99% |
|
+5.74% | +23.83% |
| Market Cap | 133B 202,954B 118B 110B 99.26B 187B 12,546B 189B 1,315B 516B 6,594B 499B 488B 21,013B | P/E 2026 * |
35x | P/E 2027 * | 28.2x |
|---|---|---|---|---|---|
| Enterprise Value | 127B 194,203B 113B 105B 94.98B 179B 12,005B 181B 1,258B 494B 6,310B 477B 467B 20,107B | EV / Sales 2026 * |
9.59x | EV / Sales 2027 * | 8.61x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| VRTX | End-of-day quote | |
Buenos Aires S.E.
| VRTXD | End-of-day quote |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | +1.99% | ||
| 1 week | +5.74% | ||
| Current month | +1.38% | ||
| 1 month | +4.83% | ||
| 3 months | +12.93% | ||
| 6 months | +33.39% | ||
| Current year | +23.83% |
| 1 week | 7,970 |  | 8,555 |
| 1 month | 7,710 | | 8,555 |
| Current year | 6,115 | | 8,825 |
| 1 year | 5,545 | | 8,825 |
| 3 years | 4,815 | | 8,825 |
| 5 years | 4,815 | | 8,825 |
| 10 years | 4,815 | | 8,825 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2020-03-31 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 2019-04-09 |
Agam Upadhyay
CTO | Chief Tech/Sci/R&D Officer | - | 2025-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 1997-12-31 |
Jeffrey Leiden
CHM | Chairman | 70 | 2012-04-30 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 2015-06-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.99% | +5.74% | - | - | 133B | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,133B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 621B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 503B | |
| +0.54% | +5.69% | +39.60% | +64.02% | 379B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 370B | |
| +0.30% | +3.44% | +21.35% | +49.62% | 292B | |
| -0.03% | +2.55% | +1.12% | +20.94% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 190B | |
| Average | +0.17% | +3.80% | +35.42% | +68.42% | 443.11B | |
| Weighted average by Cap. | +0.39% | +4.18% | +40.84% | +79.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.27B 20,256B 11.82B 10.95B 9.91B 18.66B 1,252B 18.89B 131B 51.5B 658B 49.78B 48.74B 2,097B | 14.56B 22,235B 12.98B 12.02B 10.87B 20.49B 1,374B 20.73B 144B 56.53B 722B 54.64B 53.5B 2,302B |
| Net income | 3.89B 5,939B 3.47B 3.21B 2.9B 5.47B 367B 5.54B 38.48B 15.1B 193B 14.59B 14.29B 615B | 4.89B 7,468B 4.36B 4.04B 3.65B 6.88B 462B 6.96B 48.39B 18.99B 243B 18.35B 17.97B 773B |
| Net Debt | -5.73B -8,751B -5.11B -4.73B -4.28B -8.06B -541B -8.16B -56.7B -22.25B -284B -21.5B -21.06B -906B | -7.54B -11,516B -6.72B -6.22B -5.63B -10.61B -712B -10.74B -74.62B -29.28B -374B -28.3B -27.71B -1,192B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | ARS 8,470.00 | +1.99% | 3,281 |
| 26-10-20 | ARS 8,305.00 | +3.36% | 11,709 |
| 26-10-19 | ARS 8,035.00 | +0.75% | 1,059 |
| 26-10-16 | ARS 7,975.00 | -2.03% | 1,240 |
| 26-10-15 | ARS 8,140.00 | +1.62% | 1,559 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
